Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05327894
Title Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia (Interfant-21)
Acronym Interfant-21
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Princess Maxima Center for Pediatric Oncology
Indications
Therapies
Age Groups: child
Covered Countries NLD | ITA | FRA | DEU | BEL | AUT | AUS

Additional content available in CKB BOOST